To provide updates for the 2015 Centers for Disease Control and Prevention sexually
transmitted diseases treatment guidelines on human papillomavirus (HPV) and anogenital …

A bstract Background: Human papillomaviruses (HPV) are common human pathogens and
are classified into more than 80 different types. These viruses produce benign warts in many …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

The treatment of genital warts remains frustrating since it is often painful, expensive, and
unsuccessful. Moreover, little is known about the infectivity and natural history of exophytic …

The increasing incidence of human papillomavirus (HPV) infection and HPV‐associated
conditions such as genital warts in women is a global concern. Genital warts are a clinical …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Over the past few decades, epidemiology and natural history studies have led to improved
understanding of human papillomavirus (HPV) infection and to promising prevention …

Genital human papillomavirus (HPV) is a common, usually transient, dermatologic infection
transmitted by genital contact that can cause a variety of anogenital diseases, including …

Human papillomavirus (HPV) is one of the most common sexually transmitted infections and
a significant cause of anogenital malignancies, precancer lesions, and cutaneous disease …

Many therapies are available for the treatment of human papillomavirus (HPV)-associated
disease, particularly external genital warts. However, at present, these therapies aim to …